Pinnacle Wealth Planning Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$846	Hold	201	–	–	﹤0.01%	2600
2026 Q1	$706	Hold	201	–	–	﹤0.01%	2595
2025 Q4	$677	Buy	+201	New	+$522	﹤0.01%	2625
2022 Q4	–	Sell	-10,603	Closed	-$109K	–	470
2022 Q3	$109K	Sell	10,603 -60	-0.6%	-$680	0.02%	358
2022 Q2	$123K	Buy	+10,663	New	+$126K	0.02%	371
2022 Q1	–	Sell	-10,494	Closed	-$122K	–	458
2021 Q4	$122K	Sell	10,494 -62	-0.6%	-$761	0.02%	391
2021 Q3	$138K	Buy	10,556 +160	+2%	+$2.07K	0.03%	345
2021 Q2	$134K	Buy	10,396 +44	+0.4%	+$504	0.03%	335
2021 Q1	$116K	Buy	10,352 +9,723	+1,546%	+$103K	0.03%	319
2020 Q4	$7K	Buy	+629	New	+$6.88K	﹤0.01%	1529

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pinnacle Wealth Planning Services's IRWD Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 201 shares worth $846. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Pinnacle Wealth Planning Services first reported a position in IRWD in Q4 2020 and has held it in 10 quarters since. The position peaked at $138K in Q3 2021. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Pinnacle Wealth Planning Services held 201 shares of Ironwood Pharmaceuticals worth $846 as of Q2 2026.
Pinnacle Wealth Planning Services left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2600 holding.
Pinnacle Wealth Planning Services first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 10 quarters since.
Pinnacle Wealth Planning Services's Ironwood Pharmaceuticals position peaked at $138K in Q3 2021.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.